| __timestamp | Evotec SE | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 12404000 | 347523000 |
| Thursday, January 1, 2015 | 18343000 | 479514000 |
| Friday, January 1, 2016 | 18108000 | 581861000 |
| Sunday, January 1, 2017 | 17614000 | 1326361000 |
| Monday, January 1, 2018 | 35619000 | 1197957000 |
| Tuesday, January 1, 2019 | 58432000 | 1154111000 |
| Wednesday, January 1, 2020 | 63945000 | 2215942000 |
| Friday, January 1, 2021 | 72200000 | 1458179000 |
| Saturday, January 1, 2022 | 76642000 | 1585936000 |
| Sunday, January 1, 2023 | 57519000 | 1627594000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Incyte Corporation and Evotec SE have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Incyte Corporation's R&D expenses surged by approximately 368%, peaking in 2020. This reflects their aggressive strategy to expand their drug pipeline. In contrast, Evotec SE's R&D spending grew by about 364% during the same period, with a more consistent year-on-year increase. Notably, in 2023, Incyte's R&D expenses were nearly 28 times higher than Evotec's, highlighting their larger scale of operations. These trends underscore the diverse strategies within the biotech sector, where companies balance risk and innovation to drive future growth.
Vertex Pharmaceuticals Incorporated vs Evotec SE: Strategic Focus on R&D Spending
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Evotec SE
BeiGene, Ltd. vs Incyte Corporation: Strategic Focus on R&D Spending
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
Comparing Innovation Spending: Incyte Corporation and Opthea Limited
R&D Insights: How Incyte Corporation and Amneal Pharmaceuticals, Inc. Allocate Funds
R&D Spending Showdown: Incyte Corporation vs Protagonist Therapeutics, Inc.
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Incyte Corporation or Vericel Corporation: Who Invests More in Innovation?
R&D Spending Showdown: Incyte Corporation vs Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Incyte Corporation and Geron Corporation
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and BioCryst Pharmaceuticals, Inc.